Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Daléry

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
L'Encephale|August 6, 1999
[Schizophrenia: from prediction to prevention. A challenge for the 21st century]J Daléry
L'Encephale|July 6, 2004
[Concurrent validation of the suicidal risk assessment scale (R.S.D.) with the Beck's suicidal ideation scale]J-L Ducher, J Daléry
L'Encephale|April 11, 2001
[Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence]J Daléry, V Aubin
Journal of Homosexuality|January 1, 1976
Iatrogenic homosexuality: gender identity in seven 46,XX chromosomal females with hyperadrenocortical hermaphroditism born with a penis, three reared as boys, four reared as girlsJ Money, J Daléry
L'Encephale|November 23, 2006
[Do cognitive sciences open therapeutic paths in schizophrenia?]M Saoud, M Senn, J Daléry
L'Encephale|January 1, 1997
[Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment]J Daléry, V Dagens-Lafant, C De Bodinat
Pediatrie|January 1, 1980
[Neuroleptics in children]J Daléry, B Beaufrère, J Maillet, et al.
L'Encephale|September 17, 2002
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders]H Lôo, J Daléry, J-P Macher, et al.
L'Encephale|October 22, 2003
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders]H Lôo, J Daléry, J P Macher, et al.
Presse Medicale (Paris, France : 1983)|February 3, 1990
[Treatment of Gilles de la Tourette's disease with amisulpride]M Trillet, T Moreau, J Daléry, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
L'Encephale|August 6, 1999
[Schizophrenia: from prediction to prevention. A challenge for the 21st century]J Daléry
L'Encephale|July 6, 2004
[Concurrent validation of the suicidal risk assessment scale (R.S.D.) with the Beck's suicidal ideation scale]J-L Ducher, J Daléry
L'Encephale|April 11, 2001
[Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence]J Daléry, V Aubin
Journal of Homosexuality|January 1, 1976
Iatrogenic homosexuality: gender identity in seven 46,XX chromosomal females with hyperadrenocortical hermaphroditism born with a penis, three reared as boys, four reared as girlsJ Money, J Daléry
L'Encephale|November 23, 2006
[Do cognitive sciences open therapeutic paths in schizophrenia?]M Saoud, M Senn, J Daléry
L'Encephale|January 1, 1997
[Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment]J Daléry, V Dagens-Lafant, C De Bodinat
Pediatrie|January 1, 1980
[Neuroleptics in children]J Daléry, B Beaufrère, J Maillet, et al.
L'Encephale|September 17, 2002
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders]H Lôo, J Daléry, J-P Macher, et al.
L'Encephale|October 22, 2003
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders]H Lôo, J Daléry, J P Macher, et al.
Presse Medicale (Paris, France : 1983)|February 3, 1990
[Treatment of Gilles de la Tourette's disease with amisulpride]M Trillet, T Moreau, J Daléry, et al.
Pageof 3